Nestle submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after all.
Nestle is the frontrunner to buy Merck KGaA’s consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter.
Bloomberg said Nestle had submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after all.
